OBJECTIVE: To determine the most effective, evidence-based approach to the use of platelet transfusions in patients with cancer. OUTCOMES: Outcomes of interest included prevention of morbidity and ...

Background: Transfusion-dependent bone marrow transplant recipients are routinely transfused with ABO group and RhD-compatible blood components. However, because of the scarcity of RhD-negative blood ...

Myelodysplastic syndromes (MDS) can damage bone marrow, lowering red blood cells and platelets. Transfusions replace missing cells to manage anemia or thrombocytopenia. Up to 9 in 10 people with MDS ...

A preliminary study published in this week's issue of THE LANCET suggests a possible explanation for the biological process responsible for inducing fever and related symptoms after the transfusion of ...

Four people in three states developed sepsis after receiving bacteria-contaminated platelet transfusions between May and October last year, according to a US government report released Thursday. One ...

Please provide your email address to receive an email when new articles are posted on . Patients with severe thrombocytopenia who did not receive prophylactic transfusion before catheter placement had ...

To provide evidence-based guidance on the use of platelet transfusion in people with cancer. This guideline updates and replaces the previous ASCO platelet transfusion guideline published initially in ...